IGT Statement on Senate Introduction of the MVP Act
Today, Senators Markwayne Mullin (R-OK), Kyrsten Sinema (AZ), Tim Scott (SC), and Maggie Hassan (NH) introduced the Senate companion to...
IGT Statement on Senate Introduction of the MVP Act
Health Care’s Genetic and Cellular Transformation Must Benefit All Patients in Need
IGT Responds to HRSA RFI on Nomination and Evidence-Based Review Process of the Advisory Committee on Heritable Disorders in Newborns and Children
IGT Recognizes National Minority Health Month (NMHM)
AEI Panel Discussion: Navigating Emerging Technologies in Cell and Gene Therapy
IGT Responds to Senator Bill Cassidy’s RFI on Improving Americans’ Access to Gene Therapies
Congressional Briefing: Realizing the Promise of Gene Therapy: Ensuring Access
Year In Review: Gene Therapies Make a Big Splash in 2023